Tag: Zhou Hanshuo
Lawyers analyse China’s drug trial data protection rules
China’s new drug trial data protection rules are considered a boost for development, but some lawyers warn disputes may arise
Firms advise on Insilico Medicine’s HKD2.28bn HKEX IPO
AI drug discovery firm Insilico Medicine listed on the HKEX main board on 30 December 2025






















